Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial

• Published in: The Journal of heart and lung transplantation Vol. 38; no. 3; pp. 252 - 259
• Main Authors: Van Herck, Anke, Frick, Anna E., Schaevers, Veronique, Vranckx, Annelies, Verbeken, Eric K., Vanaudenaerde, Bart M., Sacreas, Annelore, Heigl, Tobias, Neyrinck, Arne P., Van Raemdonck, Dirk, Dupont, Lieven J., Yserbyt, Jonas, Verleden, Stijn E., Verleden, Geert M., Vos, Robin
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2019
• Subjects: azithromycin; chronic lung allograft dysfunction; early lung allograft function; lung transplantation; survival; early lung allograft function; chronic lung allograft dysfunction; lung transplantation; azithromycin; survival

Chronic lung allograft dysfunction (CLAD) is the single most important factor limiting long-term survival after lung transplantation (LTx). Azithromycin has been shown to improve CLAD-free and long-term survival, yet the possible impact on early lung allograft function is unclear. A prospective, ran...